You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 31, 2024

Vietnam Issues First National Technical Regulation for Health Supplements

On July 18. 2024, Vietnam’s Ministry of Health issued Circular No. 12/2024/TT-BYT promulgating National Technical Regulation QCVN 20-1:2024/BYT on the limits of contaminants for health supplements (“Circular 12”). The new national technical regulation is the very first relating to health supplements, and is expected to have a great impact on the control of health supplement quality in Vietnam. Circular 12 will take effect on August 1, 2025.

Contents of Circular 12

The new circular prescribes limits of contaminants (heavy metals and microorganisms), testing samples and testing methods, management requirements, and responsibilities of entities manufacturing and trading in health supplements.

Supplemented alcohol products which are declared as health supplements are notably excluded from the scope of the regulation.

Transitional Provisions

Health supplements which (i) have been granted a declaration registration certificate, and (ii) are manufactured before August 1, 2025, are allowed to continue to be imported, traded, and circulated until the expiry date of the product, even if it is not aligned with Circular 12, except when there is food safety warning.

Declaration registration dossiers for health supplements submitted before August 1, 2025, will continue to be handled in accordance with the prevailing regulations at the time of submission.

From August 1, 2025, if a health supplement with a granted declaration registration certificate has a manufacturer’s standard that does not comply with Circular 12, the party manufacturing/trading in the product must adjust the product standard to conform to Circular 12 and notify the authority of this adjustment.

RELATED INSIGHTS​ 

February 14, 2017
The 2016/17 edition of the Distribution and Marketing of Drugs Global Guide, covering issues related to the marketing of drugs across 28 different jurisdictions, has been published by Practical Law. The Thailand chapter of the guide was authored by Alan Adcock, Siraprapha Rungpry, and Atthachai Homhuan from the Tilleke & Gibbins intellectual property team in Bangkok. The chapter covers issues surrounding:
February 6, 2017
Attorneys from Tilleke & Gibbins have written the Vietnam chapter of Practical Law Company’s Doing Business in … Global Guide, an essential handbook for businesses looking to expand their operations abroad. The guide provides a practical overview of the legal system in more than 50 jurisdictions worldwide, with the Vietnam chapter including the following main subjects:
January 24, 2017
The 2017 edition of Doing Business In…, a Q&A-style guide published by Practical Law Company in collaboration with Lex Mundi, presents an overview of recent legal developments affecting doing business in 51 jurisdictions worldwide. The Thailand chapter of the guide was written by attorneys from Tilleke & Gibbins and presents an overview of Thailand’s legal system and key laws applicable to foreign companies doing business in the Kingdom. The chapter specifically covers the following main topics:
January 23, 2017
With a population approaching 100 million, a burgeoning health care industry, increasing consumer affluence, and relatively weak competition from local pharmaceutical manufacturers, Vietnam would appear to be a very promising market for foreign pharmaceutical companies. A study of the pharmaceutical patent filing statistics in Vietnam reveals that foreign investors are indeed interested in the market—but perhaps are not protecting their innovations to the extent we might expect by filing patents. In this article, we examine the most recent available statistics on: